A New Era in Precision Oncology at Kokilaben Hospital At Kokilaben Dhirubhai Ambani Hospital, we believe cancer treatment should be as unique as the patient. That’s why we are proud to launch Precision Onco Haemyeloid NGS Panel – a next-generation, comprehensive genetic test designed to transform cancer care through precision oncology.
Precision Onco Haemyeloid NGS Panel is a state-of-the-art genomic profiling test that analyzes over 40 key DNA target and Fusion 29 driver genes cancer-related genes to uncover the molecular drivers of an individual’s cancer. By identifying specific genetic changes within a bone marrow aspirates and peripheral blood, this test enables oncologists to design treatment plans that are more personalized, effective, and targeted.
This test provides a deep molecular understanding of the cancer by detecting: Single Nucleotide Variants (SNVs) and small insertions/deletions Gene Fusions and Rearrangements
Genetics & Molecular Medicine, Laboratory Medicine
Cancer genomics, Molecular Pathology, Solid Tumors, Hematological Malignancies, Precision Oncology, Immunooncology, Hereditary Cancers
View Doctors
